-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-adults-screening-and-management-2012
June 15, 2012 - As a result, the USPSTF is unable to recommend medication use. … Both orlistat and metformin caused mild to moderate gastrointestinal adverse effects that resulted in medication
-
www.uspreventiveservicestaskforce.org/Home/GetFile/11/218/aspr-cvccrc-finalrsfact/pdf
April 01, 2016 - CVD risk is also influenced by whether a person has diabetes, smokes, or
takes blood pressure medication
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review40/gonorrhea-screening
May 15, 2005 - Key Questions: Newborn preventive medication
1. What are the adverse effects of treatment? … A specific search on neonatal preventive medication was also performed. … Adverse effects of preventive medication treatment for newborns. … Even with the side effects of medication accounted for, treating all women aged 18 to 31 years saved … For the topic of neonatal preventive medication, 47 citations resulted, 9 abstracts were reviewed after
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review40/gonorrhea-screening-2005
May 15, 2005 - Key Questions: Newborn preventive medication
1. What are the adverse effects of treatment? … A specific search on neonatal preventive medication was also performed. … Adverse effects of preventive medication treatment for newborns. … Even with the side effects of medication accounted for, treating all women aged 18 to 31 years saved … For the topic of neonatal preventive medication, 47 citations resulted, 9 abstracts were reviewed after
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary48/suicide-risk-screening
May 15, 2004 - an emergency information card, 62 a letter, 32 outpatient day hospitalization, 33 antidepressant medication … , 61 antipsychotic medication, 63 and DBT. 34 All interventions were compared with usual care or placebo … (for the 2 medication studies). … 1982 54
London, UK
Patients with a GHQ score ≥20 and not on antidepressant or antipsychotic medication … Two case groups (suicide completers and attempters) and 2 matched control groups to evaluate medication
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/cJSpoZqW2M7czx_-GeTdtE
May 01, 2004 - providing an emergency
information card,62 a letter,32 outpatient day
hospitalization,33 antidepressant medication … ,61
antipsychotic medication,63 and DBT.34 All
interventions were compared with usual care or
placebo … (for the 2 medication studies). … et al,
198254
London, UK
Patients with a GHQ score ≥ 20 and
not on antidepressant or antipsychotic
medication … Statistic
Two case groups
(suicide completers
and attempters) and
2 matched control
groups to evaluate
medication
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary48/suicide-risk-screening-2004
May 15, 2004 - an emergency information card, 62 a letter, 32 outpatient day hospitalization, 33 antidepressant medication … , 61 antipsychotic medication, 63 and DBT. 34 All interventions were compared with usual care or placebo … (for the 2 medication studies). … 1982 54
London, UK
Patients with a GHQ score ≥20 and not on antidepressant or antipsychotic medication … Two case groups (suicide completers and attempters) and 2 matched control groups to evaluate medication
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening-july-2014
July 08, 2014 - identification of asymptomatic carotid artery stenosis leads to any benefit from adding or increasing medication
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions-2009
April 15, 2009 - Harms of pharmacotherapy are dependent on the specific medication used.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/drug-use-illicit-screening
October 20, 2016 - dependent drug use are out of scope for this review; therefore, pharmacotherapy interventions (including medication-assisted
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/5W2k4HLBPLPgHov6sSvuMH
July 24, 2018 - Services Task Force (USPSTF) has main-
tained an “A” recommendation for prophylactic ocular topical
medication
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/RPB3rmcS9CK_eXPdzXSxZg
July 01, 2010 - risk-assessment instruments; and sys
tematic reviews and population-based studies of bone measure
ment tests or medication … Fracture Outcomes of Placebo-Controlled Primary Prevention Trials, by Type of Fracture*
Medication … Case reports of severe musculoskeletal pain that may
be reversible after discontinuing the medication … of evidence Consistent Primary prevention trials are Poor to
bisphosphonates, 1 trial of varies by medication … Adverse Health Outcomes from Studies, by Medication
Adverse Outcome Evidence
Bisphosphonates
Withdrawals
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/j69Hq5ALvzg74e-ngkzSep
April 01, 2016 - co-
morbidities (diabetes, liver disease, ulcer disease, and
previous GI bleeding), and concurrent medication … A patient's willingness and ability to use a daily
medication is another consideration for selecting … m2): 1.24 (1.13–1.35) 0.85 (0.71–1.02)
Previous GI hospitalization (yes vs. no) – – 2.87 (2.46–3.35)
Medication … Participants,
n
Mean Age
(Range), y
Women, % Diabetes, % Current
Smokers, %
Aspirin Dose and Frequency
Co-medication
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Y5p8ZXy2ydg_VZMUfxbJ-6
April 25, 2017 - Approaches to Prevention
The USPSTF recommends the use of low-dose aspirin (81 mg/d) as
preventive medication … The USPSTF recommends the use of low-dose aspirin (81 mg/d) as preventive medication after 12 weeks of
-
www.uspreventiveservicestaskforce.org/uspstf/node/133
March 01, 2018 - John B. Wong, M.D.
Member
John B. Wong, M.D., is chief scientific officer, vice chair for Clinical Affairs, chief of the Division of Clinical Decision Making, and a primary care clinician in the Department of Medicine at Tufts Medical Center. He is also director of comparative effectiveness research for th…
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/current-members/john-b-wong-md
March 01, 2018 - John B. Wong, M.D.
Member
John B. Wong, M.D., is interim chief scientific officer, vice chair for Academic Affairs, chief of the Division of Clinical Decision Making, and a primary care clinician in the Department of Medicine at Tufts Medical Center. He is also director of comparative effectiveness researc…
-
www.uspreventiveservicestaskforce.org/uspstf/john-b-wong-md
March 01, 2018 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
John B. Wong, M.D.
Member
John B. Wong, M.D., is vice chair for Academic Affairs, chief of the Division of Clinical Decision Making, and a primary care clinician in the Depar…
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/breastcanmedsbulletin.pdf
September 24, 2013 - U.S. Preventive Services Task Force Issues Final Recommendation Statement on Medications for Risk Reduction of Primary Breast Cancer in Women
U.S. Preventive Services Task Force Issues Final
Recommendation Statement on Medications for Risk Reduction of
Primary Breast Cancer in Women
WASHINGTON, D.C. – Sept. 24, …
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/tobacco-cessation-adults-draft-rec-bulletin.pdf
June 29, 2020 - U.S. Preventive Services Task Force Issues Draft Recommendation Statement on Interventions for Tobacco Cessation in Adults
www.uspreventiveservicestaskforce.org
U.S. Preventive Services Task Force Issues Draft Recommendation
Statement on Interventions for Tobacco Cessation in Adults
Task Force recommends clin…
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/tobacco-cessation-adults-final-rec-bulletin.pdf
January 19, 2021 - U.S. Preventive Services Task Force Issues Final Recommendation Statement on Interventions for Tobacco Cessation in Adults
www.uspreventiveservicestaskforce.org
U.S. Preventive Services Task Force Issues Final Recommendation
Statement on Interventions for Tobacco Cessation in Adults
Task Force recommends clin…